Challenges in treating primary immune thrombocytopenia patients undergoing COVID-19 vaccination: A retrospective study

Abstract

Since the outbreak of COVID-19 in December 2019, countries around the world, including China, have been administering COVID-19 vaccines in response to the pandemic. Our center has observed that treating patients with primary immune thrombocytopenia (ITP) has become more challenging in this context.

Keywords

• covid-19
• vaccination
• primary immune thrombocytopenia
• second-line therapy